hansen-medical Archives

Hansen Medical(R) Announces Filing of 510K for Expanded Neurological Indication for Magellan(TM) Product Line

By Publisher on April 26, 2016 Micro-electronics & Nanotechnology, Picture Gallery

MOUNTAIN VIEW, CA — (Marketwired) — 04/26/16 — Hansen Medical®, Inc. (NASDAQ: HNSN), the global leader in intravascular robotics, today provides an update on the status of its key corporate initiative to expand the utility and regulatory labeling of the Magellan product line.Hansen Medical recently submitted a 510k to the FDA for a neurological indication for the Magellan Robotic System. If successful, the Magellan Robotic System would be fully indicated for applications in peripheral va

Hansen Medical(R) to Highlight Benefits and Future of Magellan(TM) Robotic System Technology and Present Magellan Robotic System at Charing Cross International Symposium

By Publisher on April 25, 2016 Micro-electronics & Nanotechnology, Picture Gallery

MOUNTAIN VIEW, CA — (Marketwired) — 04/25/16 — Hansen Medical®, Inc. (NASDAQ: HNSN), the global leader in intravascular robotics, today announced it will exhibit its Magellan Robotic System at the Charing Cross International Symposium in London, United Kingdom from April 26th to April 29th.At the 38th annual symposium, the Magellan Robotic System and family of Magellan Robotic Catheters will be showcased and available for demonstrations at exhibit booth #215. Hansen Medical also anticipa

Auris Surgical Robotics Agrees to Acquire Hansen Medical

By Publisher on April 20, 2016 Micro-electronics & Nanotechnology, Picture Gallery

SAN CARLOS, CA and MOUNTAIN VIEW, CA — (Marketwired) — 04/20/16 — Auris Surgical Robotics, Inc. and Hansen Medical, Inc. (NASDAQ: HNSN) today announced that they have signed a definitive merger agreement under which Auris will acquire Hansen Medical for $4.00 per share in cash, or a total equity value of approximately $80 million. The purchase price per share represents a premium of approximately 39.9% over the closing sale price of common stock of Hansen Medical as reported on NASDAQ on Apr

Hansen Medical(R), Inc. Receives NASDAQ Letter Regarding Late Form 10-K Filing

By Publisher on April 6, 2016 Micro-electronics & Nanotechnology, Picture Gallery

MOUNTAIN VIEW, CA — (Marketwired) — 04/06/16 — Hansen Medical®, Inc. (NASDAQ: HNSN) today announced that it received a notification letter on March 31, 2016 from The NASDAQ Stock Market ("NASDAQ"). The notification letter stated that because the Company has not yet filed its Annual Report on Form 10-K for the year ended December 31, 2015 (the "Form 10-K"), the Company is no longer in compliance with NASDAQ Marketplace Rule 5250(c)(1), which requires timely filing of p

Hansen Medical(R) to Demonstrate New Magellan(TM) Robotic Catheter eKit and Present Magellan Robotic System at 41st Annual Society of Interventional Radiology (SIR) Scientific Meeting

By Publisher on March 17, 2016 Micro-electronics & Nanotechnology, Picture Gallery

MOUNTAIN VIEW, CA — (Marketwired) — 03/17/16 — Hansen Medical®, Inc. (NASDAQ: HNSN), the global leader in intravascular robotics, today announced it will exhibit its Magellan Robotic System at the Annual Society of Interventional Radiology (SIR) Scientific Meeting April 2-7 in Vancouver, British Columbia, Canada. The Company will showcase the newly approved Magellan Robotic Catheter eKit that has been used by Interventional Radiologists in a variety of procedures, including Uterine Fibro

Hansen Medical(R) Announces First Clinical Procedure in the US With New Magellan(TM) Robotic Catheter eKit

By Publisher on February 17, 2016 Micro-electronics & Nanotechnology, Picture Gallery

MOUNTAIN VIEW, CA — (Marketwired) — 02/17/16 — Hansen Medical®, Inc. (NASDAQ: HNSN), the global leader in intravascular robotics, today announced the completion of the first clinical procedure in the United States with the Magellan Robotic Catheter eKit (MRC eKit). Interventional Radiologist, Dr. Ripal Gandhi, performed the procedure at Miami Cardiac & Vascular Institute (MCVI) in Miami, FL. Dr. Gandhi used the MRC eKit during a robotic transarterial chemoembolization (TACE) procedur

Hansen Medical(R) Announces FDA Clearance of the Magellan(TM) Robotic Catheter eKit

By Publisher on February 2, 2016 Micro-electronics & Nanotechnology, Picture Gallery

MOUNTAIN VIEW, CA — (Marketwired) — 02/02/16 — Hansen Medical®, Inc. (NASDAQ: HNSN), the global leader in intravascular robotics, today announced it has received U.S. Food and Drug Administration (FDA) clearance for the Magellan Robotic Catheter eKit (MRC eKit). The MRC eKit is the company–s latest addition to the family of approved Magellan Robotic Catheters and helps extend robotic capabilities and control throughout procedures in the peripheral vasculature. With the MRC eKit, physici

Hansen Medical(R) Announces Latest Publication in the Journal of Interventional Cardiac Electrophysiology

By Publisher on February 1, 2016 Micro-electronics & Nanotechnology, Picture Gallery

Analysis of Catheter Contact Force During Atrial Fibrillation Ablation Using the Robotic Navigation System: Results From a Randomized Study

Hansen Medical Provides Corporate Update of Key Near-Term Clinical, Regulatory and Commercial Events

By Publisher on January 14, 2016 Micro-electronics & Nanotechnology, Picture Gallery

MOUNTAIN VIEW, CA — (Marketwired) — 01/14/16 — Hansen Medical, Inc. (NASDAQ: HNSN), the global leader in intravascular robotics, today provided an update of key corporate initiatives which, if successful, will expand the utility and regulatory labeling of the Sensei® and Magellan product lines:This study is a prospective, single arm study of the Hansen Sensei System for introducing and positioning RF ablation catheters in subjects with paroxysmal atrial fibrillation (PAF). As of January

Hansen Medical Announces Exploration of Strategic Alternatives

By Publisher on January 14, 2016 Micro-electronics & Nanotechnology, Picture Gallery

MOUNTAIN VIEW, CA — (Marketwired) — 01/14/16 — Hansen Medical, Inc. (NASDAQ: HNSN), the global leader in intravascular robotics, announced today that its board of directors has entered a process to explore strategic alternatives for the company focused on enhancing stockholder value, including, but not limited to, a licensing transaction, a refinancing transaction, a strategic business combination, partnership, a possible sale or disposition of one or more corporate assets or the company its